Items where authors include "Sivakumar, S"

Article

Bradley, SH orcid.org/0000-0002-2038-2056, Hemphill, S, Markham, S et al. (1 more author) (2022) Healthcare systems must get fair value for their data. BMJ, 377. e070876. ISSN 1759-2151

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Best, J, Starkey, T, Chatterjee, A et al. (14 more authors) (2021) Coronavirus Disease 2019: the Pivotal Role of UK Clinical Oncology and the UK Coronavirus Cancer Monitoring Project. Clinical Oncology, 33 (1). E50-E53. ISSN 0936-6555

Lee, LYW, Cazier, J-B, Starkey, T et al. (37 more authors) (2020) COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. The Lancet Oncology. ISSN 1470-2045

Lee, LYW, Cazier, J-B, Angelis, V et al. (36 more authors) (2020) COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. The Lancet, 395 (10241). pp. 1919-1926. ISSN 0140-6736

Anil, I, Arnold, R, Benkwitz-Beford, S et al. (27 more authors) (2020) The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19. The Lancet Oncology, 21 (5). pp. 622-624. ISSN 1470-2045

de Santiago, I, Yau, C, Heij, L et al. (5 more authors) (2019) Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes. International Journal of Cancer, 145 (4). pp. 1125-1137. ISSN 0020-7136

Sivakumar, S, Taccone, FS, Desai, KA et al. (2497 more authors) (2016) ESICM LIVES 2016: part two. Intensive Care Medicine Experimental, 4 (S1).